Clinical Trials on Dysequilibrium Syndrome
Total 33905 results
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Associazione Qol-oneTerminatedMyelodysplastic SyndromesFrance, Italy, Greece
-
Helsinn Healthcare SACompletedMyelodysplastic SyndromeUnited States
-
Novartis PharmaceuticalsTerminated
-
Boehringer IngelheimTerminatedMyelodysplastic SyndromesJapan
-
Association pour la recherche sur les Affections...CompletedMyelodysplastic Syndromes
-
Larry Cripe, MDCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.; Walther Cancer InstituteTerminatedMyelodysplastic SyndromesUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnMyelodysplastic SyndromesUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Washington University School of MedicineCompletedMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Xian-Janssen Pharmaceutical Ltd.CompletedMyelodysplastic SyndromeChina
-
Janssen-Cilag International NVCompletedMyelodysplastic SyndromesFrance, Germany, Bulgaria, Greece, Russian Federation
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromesUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedMyelodysplastic SyndromesSwitzerland
-
Eisai Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Neal Young, M.D.CompletedMyelodysplastic SyndromeUnited States
-
PETHEMA FoundationRoche Pharma AG; Celgene CorporationTerminatedMyelodysplastic SyndromeSpain
-
Groupe Francophone des MyelodysplasiesGenzyme, a Sanofi CompanyCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedMyelodysplastic SyndromesUnited States
-
Janssen Pharmaceutical K.K.CompletedMyelodysplastic SyndromeJapan
-
Duke UniversityCelgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
Eisai Inc.CompletedMyelodysplastic SyndromeUnited States, Canada
-
Seoul National University HospitalCompletedMyelodysplastic SyndromesKorea, Republic of
-
European Organisation for Research and Treatment...WithdrawnMyelodysplastic SyndromesFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Fondazione Italiana Sindromi Mielodisplastiche-ETSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteTerminated
-
Basque Health ServiceUnknown
-
Cooperative Study Group A for HematologyUnknownMyelodysplastic SyndromeKorea, Republic of
-
AmgenCompletedMyelodysplastic Syndromes
-
Tel-Aviv Sourasky Medical CenterUnknownMyelodysplastic SyndromeIsrael
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
NovaceaUnknownMyelodysplastic SyndromeUnited States
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
Centre Hospitalier Universitaire de BesanconUnknownIntra-Abdominal Hypertension | Abdominal Compartment Syndrome
-
Marathon Pharmaceuticals, LLCWithdrawnShort Bowel Syndrome | Short Gut Syndrome | SBS | Short Gut | Short BowelUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruiting
-
Kind Pharmaceuticals LLCNot yet recruitingMyelodysplastic Syndromes
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
Syros PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States, Spain, Belgium, Israel, France, United Kingdom, Austria, Czechia, Italy, Poland, Canada, Hungary, Germany
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingMyelodysplastic SyndromesItaly
-
Syntrix Biosystems, Inc.Johns Hopkins University; Mayo Clinic; National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingMyelodysplastic SyndromesUnited States
-
Centre Hospitalier Universitaire, AmiensRecruitingMyelodysplastic SyndromesFrance
-
The University of Hong KongRecruiting
-
Washington University School of MedicineSunesis PharmaceuticalsCompletedMyelodysplastic SyndromesUnited States